Results 91 to 100 of about 79,327 (229)
Assessment of Antibodies Induced by Multivalent Transmission-Blocking Malaria Vaccines
A malaria transmission-blocking vaccine would be a critical tool in achieving malaria elimination and eradication. By using chimpanzee adenovirus serotype 63 and modified vaccinia virus Ankara viral vectored vaccines, we investigated whether ...
Vinay Menon +8 more
doaj +1 more source
Epidemiology of Malaria in an Area Prepared for Clinical Trials in Korogwe, North-eastern Tanzania. [PDF]
Site preparation is a pre-requesite in conducting malaria vaccines trials. This study was conducted in 12 villages to determine malariometric indices and associated risk factors, during long and short rainy seasons, in an area with varying malaria ...
Acleus S Rutta +33 more
core +3 more sources
ABSTRACT Background COVID‐19 has had major global health impacts, yet reported morbidity and mortality have been lower in Africa despite serological evidence of widespread infection. Malaria has been proposed as a potential modifier of susceptibility to and outcomes of SARS‐CoV‐2 infection.
Ludoviko Zirimenya +22 more
wiley +1 more source
Abstract Blood transfusion is life‐saving for patients in emergencies, but low‐ and middle‐income countries (LMICs) often face a severe shortage of banked blood. Establishing blood banks in rural areas presents substantial logistical and economic challenges for many LMICs.
Suvro Sankha Datta +4 more
wiley +1 more source
Abstract BACKGROUND Rabies continues to pose a major public health threat, causing approximately 59 000 deaths each year, especially in regions with limited resources where high costs restrict vaccine access. Safer and scalable vaccine platforms, such as virus‐like particles, are promising alternatives, but their production is highly sensitive to ...
Júlia Públio Rabello +8 more
wiley +1 more source
Malaria Vaccine Development: The Need for Novel Approaches: A Review Article
Background: Although rigorous efforts have substantially decreased the malaria burden through decades, it still threatens the lives of millions of children. Development of an effective vaccine can provide important approach in malaria control strategies.
Shima MAHMOUDI, Hossein KESHAVARZ
doaj
Advances in transmission-blocking vaccines against Plasmodium falciparum and Plasmodium vivax
Introduction The World Health Organization has recommended two pre-erythrocytic malaria vaccines targeting Plasmodium falciparum. However, there is currently no vaccine available for Plasmodium vivax, the second leading cause of malaria.
Mayumi Tachibana +5 more
doaj +1 more source
Public Health Achievements in Rwanda: A 21st Century Transformation
This narrative review examines Rwanda's post‐2000 public health transformation using the WHO health system building blocks. It shows how strategic governance, universal health coverage via mutuelle de santé, community health workers, and digital health tools have driven substantial gains in maternal/child health, infectious disease control, and ...
Niyibizi Julius +2 more
wiley +1 more source
A landscape review of malaria vaccine candidates in the pipeline
Background Globally, malaria continues to pose a major health challenge, with approximately 247 million cases of the illness and 627,000 deaths reported in 2021.
Yusuf Amuda Tajudeen +15 more
doaj +1 more source
Costing the supply chain for delivery of ACT and RDTs in the public sector in Benin and Kenya [PDF]
Studies have shown that supply chain costs are a significant proportion of total programme costs. Nevertheless, the costs of delivering specific products are poorly understood and ballpark estimates are often used to inadequately plan for the budgetary ...
Anupindi, Ravi +6 more
core +5 more sources

